← All stories
Markets
BioSyent Releases Financial Results for Q2 and H1 2026
MISSISSAUGA, Ontario, Aug. 20, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its consolidated financial results for the three months (Q2), six months (H1), and trailing twelve months (TTM) ended June 30,…
Covered by 1 outlet
All coverage · 1 article